Treatment with nanosomal paclitaxel lipid suspension conventional paclitaxel in metastatic breast cancer patients – a multicenter, randomized, comparative, phase II/III clinical study

Autor: Chiradoni Thungappa Satheesh, Rakesh Taran, Jitendra Kumar Singh, Shanti Prakash Shrivastav, Nikunj K. Vithalani, Kalyan Kusum Mukherjee, Rajnish Vasant Nagarkar, Tanveer Maksud, Ajay Omprakash Mehta, Krishnan Srinivasan, Mummaneni Vikranth, Satish Ramkrishna Sonawane, Ateeq Ahmad, Saifuddin Sheikh, Shoukath M. Ali, Ronak Patel, Mahesh Paithankar, Lav Patel, Anil Rajani, Deepak Bunger, Alok Chaturvedi, Imran Ahmad

Publikováno v: Therapeutic Advances in Medical Oncology, Vol 16 (2024)

Background: A novel nanosomal paclitaxel lipid suspension (NPLS), free from Cremophor EL (CrEL) and ethanol, was developed to address the solvent-related toxicities associated with conventional paclitaxel formulation. Objective: To evaluate the effic

Externí odkaz: https://doaj.org/article/195a2e09073747269a55c7d3f9764a63

Synergies between centralized and federated approaches to data quality: a report from the national COVID cohort collaborative

Autor: Emily R, Pfaff, Andrew T, Girvin, Davera L, Gabriel, Kristin, Kostka, Michele, Morris, Matvey B, Palchuk, Harold P, Lehmann, Benjamin, Amor, Mark, Bissell, Katie R, Bradwell, Sigfried, Gold, Stephanie S, Hong, Johanna, Loomba, Amin, Manna, Julie A, McMurry, Emily, Niehaus, Nabeel, Qureshi, Anita, Walden, Xiaohan Tanner, Zhang, Richard L, Zhu, Richard A, Moffitt, Melissa A, Haendel, Christopher G, Chute, William G, Adams, Shaymaa, Al-Shukri, Alfred, Anzalone, Ahmad, Baghal, Tellen D, Bennett, Elmer V, Bernstam, Mark M, Bissell, Brian, Bush, Thomas R, Campion, Victor, Castro, Jack, Chang, Deepa D, Chaudhari, Wenjin, Chen, San, Chu, James J, Cimino, Keith A, Crandall, Mark, Crooks, Sara J Deakyne, Davies, John, DiPalazzo, David, Dorr, Dan, Eckrich, Sarah E, Eltinge, Daniel G, Fort, George, Golovko, Snehil, Gupta, Janos G, Hajagos, David A, Hanauer, Brett M, Harnett, Ronald, Horswell, Nancy, Huang, Steven G, Johnson, Michael, Kahn, Kamil, Khanipov, Curtis, Kieler, Katherine Ruiz De, Luzuriaga, Sarah, Maidlow, Ashley, Martinez, Jomol, Mathew, James C, McClay, Gabriel, McMahan, Brian, Melancon, Stephane, Meystre, Lucio, Miele, Hiroki, Morizono, Ray, Pablo, Lav, Patel, Jimmy, Phuong, Daniel J, Popham, Claudia, Pulgarin, Carlos, Santos, Indra Neil, Sarkar, Nancy, Sazo, Soko, Setoguchi, Selvin, Soby, Sirisha, Surampalli, Christine, Suver, Uma Maheswara Reddy, Vangala, Shyam, Visweswaran, James von, Oehsen, Kellie M, Walters, Laura, Wiley, David A, Williams, Adrian, Zai

Publikováno v: Journal of the American Medical Informatics Association : JAMIA

Objective In response to COVID-19, the informatics community united to aggregate as much clinical data as possible to characterize this new disease and reduce its impact through collaborative analytics. The National COVID Cohort Collaborative (N3C) i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3533d16eaddda730bcfae1d98babd62d
https://ora.ox.ac.uk/objects/uuid:b846d295-7fb7-4e4f-b878-2edbdca8fe09

Disease profile of Guillain-Barré syndrome among Indian patients receiving intravenous immunoglobulin: a real-world observational study

Autor: Anil Rajani, Lav Patel, Shreekant Sharma

Publikováno v: International Journal of Scientific Reports. 8:362

Background: Objectives of the study were to evaluate the real-world usage pattern of intravenous immunoglobulin (IVIg) for the treatment of patients with Guillain‐Barré syndrome (GBS), and to understand the disease characteristics and demographic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::063b7ffd5e9aa720f8bec3d35ee2f1db
https://doi.org/10.18203/issn.2454-2156.intjscirep20223001

Real-world utilization and acceptance of tacrolimus-based immunosuppression in solid organ transplant recipients in India

Autor: Lav Patel, Shreekant Sharma, Deepak Bunger

Publikováno v: International Journal of Clinical Trials. 9:263

Background: The objectives of the study were to describe the demographics and utilization pattern of tacrolimus (TAC)-based immunosuppressive regimens in recipients with solid organ transplant in India.Methods: This real-world, multicenter (134 cente

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::71496b07356ecf278008eebe9e4aa735
https://doi.org/10.18203/2349-3259.ijct20222626